Jonathan Chung to Cell Line, Tumor
This is a "connection" page, showing publications Jonathan Chung has written about Cell Line, Tumor.
Connection Strength
0.076
-
Acquired FGFR and FGF Alterations Confer Resistance to Estrogen Receptor (ER) Targeted Therapy in ER+ Metastatic Breast Cancer. Clin Cancer Res. 2020 11 15; 26(22):5974-5989.
Score: 0.031
-
RET rearrangements are actionable alterations in breast cancer. Nat Commun. 2018 11 16; 9(1):4821.
Score: 0.028
-
Targeted mutations in the ATR pathway define agent-specific requirements for cancer cell growth and survival. Mol Cancer Ther. 2012 Jan; 11(1):98-107.
Score: 0.017